Skip to content
DefDex

Federal award

DMS PHARMACEUTICAL GROUP INC

Y034

Contract

Obligated and Ceiling

Obligated (net)
$75,777.58
Ceiling (potential value, not spending)
$75,777.58
Current value
$75,777.58
Gross positive obligations
$75,777.58

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Owner company
DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
Reported parent
DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
Awarding agency
Department of Defense · sub-agency 97AS · office SPM2DX
Funding agency
Department of Defense · sub-agency 97AS
Product or service (PSC)
6505 · DRUGS AND BIOLOGICALS
Industry (NAICS)
325411 · MEDICINAL AND BOTANICAL MANUFACTURING
PIID
Y034
Parent vehicle (IDV PIID)
SPM2DX10D0169
Award type code
C
Actions
1 · May 29, 2015 to May 29, 2015
Why it is listed
reviewed company, $10k or more

Open this award on USAspending →

Action History1

Award actions
DateFYModAction typeObligationCompany in company totals
May 29, 2015FY20150—$75,777.58

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.